Vitamin B3 Glioblastoma Trial Study 2026: Can Niacin Help Fight Aggressive Brain Cancer?
The vitamin B3 glioblastoma trial study 2026 from the University of Calgary is giving new hope in the fight against one of the deadliest cancers. Early results from a Phase I/II clinical trial show that high-dose vitamin B3 — also known as niacin — may strengthen the immune response against glioblastoma, an aggressive brain cancer with a median survival of only about 15 months. Here is what the researchers found, how the science works, and what it could mean for patients.
What Is Glioblastoma?
Glioblastoma is the most aggressive brain cancer in adults. Tumor cells spread into surrounding brain tissue, which makes complete surgical removal nearly impossible. Standard treatment — surgery followed by radiation and chemotherapy — has barely improved survival in two decades, and the cancer frequently returns. One of the biggest challenges is that glioblastoma actively suppresses the patient's immune system, leaving the body unable to fight the tumor.
Vitamin B3 Glioblastoma Trial Study 2026: The Key Findings
Researchers at the University of Calgary, led by Dr. Wee Yong and Dr. Gloria Roldan Urgoiti of the Hotchkiss Brain Institute, published early interim results in the Journal of Neuro-Oncology. The vitamin B3 glioblastoma trial study 2026 is testing controlled-release niacin alongside standard chemotherapy and radiotherapy. The numbers so far:
- 82% of the first 24 participants had no cancer progression at six months.
- That is 28% higher than the historical benchmark from earlier studies.
- The trial beat its own prespecified bar — researchers planned to stop if progression-free survival did not improve by at least 20%.
- The full trial will enroll 48 participants, with final analysis expected by late 2026 or early 2027.
The research began in the lab, where niacin extended survival in mice before moving to human trials. The Canadian Association for Neuroscience highlighted the work in its coverage of the UCalgary study, and Medical Dialogues included it in its October 2026 medical bulletin.
How Does Niacin Fight Brain Cancer?
The mechanism is fascinating. Normally, the immune system tries to counter tumor growth — but glioblastoma shuts that defense down. Dr. Yong explains that niacin treatment appears to rejuvenate exhausted immune cells, restoring their ability to attack and destroy cancer cells. He describes it as an ongoing "battle for the brain": the vitamin rearms the immune system so it can do what it is supposed to do.
This fits a broader pattern. A separate large-scale study found that vitamin B3 in the form of nicotinamide reduced skin cancer recurrence by 14% in high-risk patients, suggesting the nutrient may have wider anti-cancer potential worth investigating.
Can You Get Vitamin B3 From Food?
Vitamin B3 occurs naturally in many foods, including chicken, turkey, tuna, salmon, brown rice, peanuts, mushrooms, and avocados. A balanced diet covers the daily requirement for most healthy adults. However — and this is critical — the trial uses high-dose, controlled-release niacin under strict medical supervision. High-dose niacin can cause serious side effects, including liver damage, so no one should self-dose based on these early findings.
What Comes Next — and What It Means for You
The results are encouraging but preliminary: a small trial, short follow-up, and final analysis still pending. If the full 48-patient data holds up, niacin could become an affordable add-on to standard glioblastoma treatment — a remarkable prospect for an incurable cancer. Researchers are watching progression-free survival closely, and larger trials would need to follow before any treatment guidelines change.
If you found this study interesting, you may also like our coverage of the walk faster live longer study on walking pace and longevity and the vitamin B12 deficiency fracture risk study — both show how everyday factors connect to long-term health.
Disclaimer: This article is for educational purposes only and is not medical advice. Always consult a qualified healthcare professional about cancer treatment. Do not take high-dose niacin without medical supervision.